GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 c ...
Ted Jin, founder and CEO of AuX Labs, is leading a charge in the food technology space with a mission driven by global impact ...
This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
Smithsonian Magazine on MSN
Horseshoe Crab Blood Has Long Helped Us Make Safe Medicines. Now, Alternatives That Spare the Ancient Creatures Might Be Breaking Through
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...
Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...
Preclinical studies have shown CPV-104 to be functionally equivalent to endogenous human Factor H, with the ability to normalize serum C3 levels and promote clearance of pathogenic complement deposits ...
EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...
Ferring Pharmaceuticals Presents Two New Analyses of Pivotal Trial Data for Follitropin Delta (FE 999049) at ASRM 2025 ...
The EVERY Co has urged a court in Wisconsin to toss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents.
Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback